As proof of concept, silencing of In1-ghrelin expression significantly reduced NFPA cell viability, which is particularly relevant in this kind of pituitary adenomas since the main comorbidities are derived from tumor overgrowth and mass effects43. Here, GHRL is linked to neoplasm.